Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Acquired by Blair William & Co. IL

Blair William & Co. IL increased its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 4.4% during the second quarter, Holdings Channel.com reports. The fund owned 84,477 shares of the company’s stock after buying an additional 3,594 shares during the period. Blair William & Co. IL’s holdings in Prestige Consumer Healthcare were worth $5,816,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of PBH. Principal Securities Inc. purchased a new stake in shares of Prestige Consumer Healthcare during the fourth quarter worth $29,000. Vanguard Personalized Indexing Management LLC purchased a new position in Prestige Consumer Healthcare during the fourth quarter worth approximately $222,000. Norges Bank acquired a new position in Prestige Consumer Healthcare during the fourth quarter worth $27,739,000. UBS Group AG grew its holdings in Prestige Consumer Healthcare by 377.6% in the 4th quarter. UBS Group AG now owns 131,382 shares of the company’s stock valued at $8,043,000 after buying an additional 103,872 shares in the last quarter. Finally, Clearbridge Investments LLC increased its stake in shares of Prestige Consumer Healthcare by 0.6% in the 4th quarter. Clearbridge Investments LLC now owns 279,917 shares of the company’s stock worth $17,137,000 after acquiring an additional 1,621 shares during the last quarter. 99.95% of the stock is owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Trading Down 1.2 %

PBH opened at $73.03 on Friday. The stock has a market capitalization of $3.63 billion, a PE ratio of 17.51, a P/E/G ratio of 2.08 and a beta of 0.48. Prestige Consumer Healthcare Inc. has a one year low of $56.34 and a one year high of $75.80. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.90 and a current ratio of 3.23. The business’s 50 day moving average price is $71.22 and its 200 day moving average price is $69.66.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.90 EPS for the quarter, beating the consensus estimate of $0.86 by $0.04. The business had revenue of $267.10 million for the quarter, compared to analyst estimates of $260.54 million. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The company’s quarterly revenue was down 4.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.06 EPS. As a group, equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current year.

Analysts Set New Price Targets

Separately, DA Davidson boosted their price target on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Wednesday, August 28th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $98.75.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.